Neuro Therapies
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
48
NCT07050316
Intranasal Administration of Dodecyl Creatine Ester (CBT101) in Healthy Male Subjects
Phase: Phase 1
Role: Lead Sponsor
Start: Mar 14, 2025
Completion: Sep 30, 2025
Loading map...